Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest announcement is out from Sun Pharmaceutical Industries Limited ( (IN:SUNPHARMA) ).
Sun Pharmaceutical Industries Limited has announced the schedule for an upcoming analyst and institutional investor meeting, which will take place in Mumbai on June 25, 2025. The meeting, part of the Nuvama Specialty Chemicals & Healthcare Day, will include both group and one-on-one sessions. The company has clarified that no unpublished price-sensitive information will be disclosed during these meetings, and the schedule is subject to change due to potential exigencies.
More about Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited operates in the pharmaceutical industry, focusing on the development, manufacture, and marketing of pharmaceutical formulations and active pharmaceutical ingredients. The company is known for its specialty generics and branded formulations, primarily serving markets in India and abroad.
Average Trading Volume: 90,867
Current Market Cap: 3992.4B INR
For a thorough assessment of SUNPHARMA stock, go to TipRanks’ Stock Analysis page.